Every SEC Form 3/4/5 on record for this filer (CIK 1793200) — 4 issuers, 36 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| CYTK | CYTOKINETICS INC | EVP, Chief Financial Officer | 2024-04-30 → 2026-06-29 | 12 | −$6M |
| TNGX | Tango Therapeutics, Inc. | Director | 2026-01-06 → 2026-06-08 | 4 | — |
| VIR | Vir Biotechnology, Inc. | EVP & Chief Financial Officer · lapsed | 2023-03-29 → 2024-03-28 | 4 | −$59,419 |
| SGMO | SANGAMO THERAPEUTICS, INC | EVP, Chief Financial Officer · lapsed | 2019-11-05 → 2020-11-30 | 4 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| CYTK | 2026-06-29 | Sell | 3,134 | $85.00 | $266,390 | 63,221 |
3 of 4 issuers are covered and open a security page; the rest are on file here only.